Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alvotech (ALVO)

Alvotech (ALVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 418,750
  • Shares Outstanding, K 31,250
  • Annual Sales, $ 91,430 K
  • Annual Income, $ -551,730 K
  • 60-Month Beta 0.07
  • Price/Sales 39.05
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ALVO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.04
  • Number of Estimates 1
  • High Estimate 0.04
  • Low Estimate 0.04
  • Prior Year -0.33
  • Growth Rate Est. (year over year) +112.12%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.01 +23.80%
on 04/02/24
14.29 -4.62%
on 03/25/24
-1.32 (-8.83%)
since 03/22/24
3-Month
11.01 +23.80%
on 04/02/24
18.00 -24.28%
on 02/26/24
-0.62 (-4.35%)
since 01/24/24
52-Week
6.70 +103.43%
on 06/29/23
18.00 -24.28%
on 02/26/24
+4.64 (+51.61%)
since 04/24/23

Most Recent Stories

More News
Alvotech and JAMP Pharma announce receipt of marketing authorization for PrJamtekiTM (AVT04), the first biosimilar of Stelara® (ustekinumab)

/CNW/ - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and...

ALVO : 13.62 (+1.64%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech SA - ALVO

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alvotech SA ("Alvotech" or the "Company") (NASDAQ: ALVO). Such investors are...

ALVO : 13.62 (+1.64%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech SA - ALVO

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alvotech SA ("Alvotech" or the "Company") (NASDAQ: ALVO). Such investors are...

ALVO : 13.62 (+1.64%)
Why Shares of Alvotech Are Jumping Friday

The biosimilar drug company's shares rebounded a day after it announced that the FDA had dealt it setback.

ABBV : 168.24 (-0.77%)
ALVO : 13.62 (+1.64%)
ALVO, ALVOW INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO, ALVOW

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of...

ALVO : 13.62 (+1.64%)
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVOW

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...

ALVO : 13.62 (+1.64%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alvotech ("Alvotech" or the "Company") (NASDAQ: ALVO). Such investors are...

ALVO : 13.62 (+1.64%)
ALVO, ALVOW INVESTOR NEWS: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Alvotech Investors With Losses in Excess of $100K to Inquire About Securities Class Action Investigation – ALVOW

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Alvotech (NASDAQ: ALVO, ALVOW) resulting from allegations...

ALVO : 13.62 (+1.64%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alvotech ("Alvotech" or the "Company") (NASDAQ: ALVO). Such investors are...

ALVO : 13.62 (+1.64%)
ALVOTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating Alvotech on Behalf of Alvotech Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Alvotech (“Alvotech” or the “Company”) (NASDAQ: ALVO) on behalf of Alvotech...

ALVO : 13.62 (+1.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Alvotech Holdings S.A. is a biotech company. It focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech Holdings S.A., formerly known as Oaktree Acquisition Corp. II, is based in REYKJAVIK, Iceland.

See More

Key Turning Points

3rd Resistance Point 13.62
2nd Resistance Point 13.53
1st Resistance Point 13.47
Last Price 13.62
1st Support Level 13.32
2nd Support Level 13.23
3rd Support Level 13.17

See More

52-Week High 18.00
Fibonacci 61.8% 13.68
Last Price 13.62
Fibonacci 50% 12.35
Fibonacci 38.2% 11.02
52-Week Low 6.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar